. "Erratum: Pembrolizumab or Placebo Plus Adjuvant Chemotherapy With or Without Radiotherapy for Newly Diagnosed, High-Risk Endometrial Cancer: Results in Mismatch Repair-Deficient Tumors." Journal of Clinical Oncology (2025). https://doi.org/10.1200/jco-24-02691